Document is current

Any future updates will be listed below

Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study

Crossref DOI link: https://doi.org/10.1186/1471-2334-14-S2-O6

Published Online: 2014-05-23

Published Print: 2014-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark